Centro de Distúrbios Urinários Infantis (CEDIMI), Escola Bahiana de Medicina e Saúde Pública, Salvador, Bahia, Brasil.
Int Braz J Urol. 2025 Jan-Feb;51(1). doi: 10.1590/S1677-5538.IBJU.2024.0453.
Although parasacral TENS (pTENS) has been employed in various centers, there is a lack of studies on how children with overactive bladder (OAB) respond after failing to complete pTENS sessions. This study aimed to describe and assess treatments for OAB in children who did not respond to pTENS.
This retrospective case series examined patients aged 4-17 years. Patients were given subsequent treatment options, including: behavioral therapies; oxybutynin; imipramine; a combination of oxybutynin and imipramine; parasacral percutaneous electrical nerve stimulation (PENS); or a repeat course of pTENS. Outcomes were evaluated using the Dysfunctional Voiding Scoring System (DVSS) and the Visual Analogue Scale (VAS).
Thirty children were included, with a median age of 7 years. Patients received one or more treatments. Of these, 70% underwent monotherapy. Among them, 57% experienced complete resolution of symptoms, 28% had partial resolution and were satisfied with the results, and 14% discontinued treatment. 30% out of the whole sample continued to experience bothersome symptoms. Complete response, according to initial subsequent, was achieved in: 54% with intensified behavioral therapies, 33% with oxybutynin, and 50% with imipramine alone. The median DVSS score decreased from 7.0 to 2.0 (p=0.025), while the median VAS score increased from 80 to 100 (p<0.001).
Children with OAB refractory to pTENS who received structured subsequent treatments showed partial response in all cases, with complete symptom resolution in half of the patients. More intensive urotherapy, medications, or repeat pTENS in combination with oxybutinin can be effective for managing this challenging condition.
虽然骶旁经皮神经电刺激(pTENS)已在多个中心应用,但对于未能完成 pTENS 疗程的儿童,其对膀胱过度活动症(OAB)的反应如何,缺乏相关研究。本研究旨在描述和评估对 pTENS 无反应的儿童的 OAB 治疗方法。
本回顾性病例系列研究纳入 4-17 岁的患者。为患者提供了以下后续治疗选择:行为疗法;奥昔布宁;丙咪嗪;奥昔布宁和丙咪嗪联合治疗;骶旁经皮电神经刺激(PENS);或重复 pTENS 疗程。采用排尿功能障碍评分系统(DVSS)和视觉模拟评分(VAS)评估疗效。
共纳入 30 例患儿,中位年龄为 7 岁。患者接受了一种或多种治疗。其中,70%的患者接受了单一药物治疗。在这些患者中,57%的症状完全缓解,28%的症状部分缓解且满意,14%的患者停止治疗。30%的患者仍有明显的症状。根据初始后续治疗,完全缓解的患者占:强化行为疗法 54%,奥昔布宁 33%,丙咪嗪 50%。DVSS 评分中位数从 7.0 降至 2.0(p=0.025),VAS 评分中位数从 80 增至 100(p<0.001)。
对 pTENS 无反应的 OAB 患儿接受结构化的后续治疗后,所有患儿均有部分反应,半数患儿完全缓解症状。更强化的尿动力学治疗、药物治疗或重复 pTENS 联合奥昔布宁可能对治疗这种具有挑战性的疾病有效。